Evidence map›Paper›PMID 32426746›Full record

ArticleCritical care explorations2020

Assessing the Course of Organ Dysfunction Using Joint Longitudinal and Time-to-Event Modeling in the Vasopressin and Septic Shock Trial.

Michael O Harhay, Alessandro Gasparini, Allan J Walkey, Gary E Weissman, Michael J Crowther, Sarah J Ratcliffe, James A Russell

Open access · goldAbstract read
In one paragraph

Article in Critical care explorations, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Personalized Blood Pressure Targets in Shock: What If Your Normal Blood Pressure Is "Low"?American journal of respiratory and critical care medicine · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Michael O HarhayPalliative and Advanced Illness Research (PAIR) Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Alessandro GaspariniBiostatistics Research Group, Department of Health Sciences, University of Leicester, Leicester, United Kingdom.
Allan J WalkeyEvans Center for Implementation and Improvement Sciences, Department of Medicine and the Pulmonary Center, Boston University School of Medicine, Boston, MA.
Gary E WeissmanPalliative and Advanced Illness Research (PAIR) Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Michael J CrowtherBiostatistics Research Group, Department of Health Sciences, University of Leicester, Leicester, United Kingdom.
Sarah J RatcliffeDivision of Biostatistics, Department of Public Health Sciences, University of Virginia, Charlottesville, VA.
James A RussellCentre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada.
University of Leicester · GBUniversity of Pennsylvania · USUniversity of British Columbia · CAUniversity of Virginia · US

Funding

Targeting cardiovascular events to improve patient outcomes after sepsisR01HL139751 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WALKEY, ALLAN J. · 2018 to 2021
$2.8M
Automated detection and prediction of atrial fibrillation during sepsisR01HL136660 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WALKEY, ALLAN J. · 2017 to 2020
$2.2M
Semi-parametric joint models for longitudinal and time to event dataR01GM104470 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI GUO, WENSHENG, RATCLIFFE, SARAH J · 2013 to 2016
$1.2M
Using natural language processing and machine learning to identify potentially preventable hospital admissions among outpatients with chronic lung diseasesK23HL141639 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI WEISSMAN, GARY · 2018 to 2022
$933k
Improving the measurement and analysis of long-term, patient-centered outcomes following acute respiratory failureR00HL141678 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI HARHAY, MICHAEL OSCAR · 2020 to 2022
$747k
Improving the measurement and analysis of long-term, patient-centered outcomes following acute respiratory failureK99HL141678 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI HARHAY, MICHAEL OSCAR · 2018 to 2019
$214k
NHLBI NIH HHS K23 HL141639NHLBI NIH HHS K99 HL141678NHLBI NIH HHS R00 HL141678NHLBI NIH HHS R01 HL136660NHLBI NIH HHS R01 HL139751NIGMS NIH HHS R01 GM104470
6 · The paper itself

Abstract

Non-mortality septic shock outcomes (e.g., Sequential Organ Failure Assessment score) are important clinical endpoints in pivotal sepsis trials. However, comparisons of observed longitudinal non-mortality outcomes between study groups can be biased if death is unequal between study groups or is associated with an intervention (i.e., informative censoring). We compared the effects of vasopressin versus norepinephrine on the Sequential Organ Failure Assessment score in the Vasopressin and Septic Shock Trial to illustrate the use of joint modeling to help minimize potential bias from informative censoring.

designSecondary analysis of the Vasopressin and Septic Shock Trial data.

settingTwenty-seven ICUs in Canada, Australia, and United States. SUBJECTS: Seven hundred sixty-three participants with septic shock who received blinded vasopressin ( MEASUREMENTS AND MAIN

resultsSequential Organ Failure Assessment scores were calculated daily until discharge, death, or day 28 after randomization. Mortality was numerically higher in the norepinephrine arm (28 d mortality of 39% vs 35%;

conclusionsShort-term reversal of organ dysfunction occurred more rapidly with norepinephrine compared with vasopressin, although differences between study arms did not persist after day 4. Joint models are an accessible methodology that could be used in critical care trials to assess the effects of interventions on the longitudinal progression of key outcomes (e.g., organ dysfunction, biomarkers, or quality of life) that may be informatively truncated by death or other censoring events.

Indexed as

joint modelingorgan dysfunctionrandomized clinical trialsepsisSequential Organ Failure Assessment

Identifiers

PMID32426746
PMCPMC7188432
OpenAlexW3016466041

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.